Abstract
Metastatic lung cancer has a poor prognosis, with a mortality of more than 80% within one year. As chemo- and radiotherapy are both effective in the palliation of symptoms, the emphasis of management is often too much put on these therapies, inducing unrealistic expectations. Since the most important aspect of caring for patients with metastatic lung cancer is to optimize or restore their quality of life (QoL), we need to integrate standard oncologic therapy with early palliative care to achieve a better understanding of the disease by the patient and his caregivers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
